Molecular control of B Lymphocyte growth and differentiation
- 1 January 1994
- journal article
- review article
- Published by Oxford University Press (OUP) in The International Journal of Cell Cloning
- Vol. 12 (3) , 278-288
- https://doi.org/10.1002/stem.5530120304
Abstract
During antigen driven immune responses, antigen-specific naive B lymphocytes undergo a cascade of events including activation, expansion, mutations, isotype switch, selections and differentiation into either antibody secreting plasma cells or memory B cells. These antigen-dependent events, which we propose to call immunopoiesis, occur in different areas of secondary lymphoid organs, as well as other nonlymphoid organs. B cells interact with antigens and numerous cell types (T cells, dendritic cells, follicular dendritic cells and macrophages) through numerous cell surface molecules and cytokines. B cells costimulated through their antigen receptor and cytokines such as interleukin 2 (IL-2), IL-4 and IL-10 undergo limited proliferation and differentiation into immunoglobulin (Ig) secreting cells. In contrast, crosslinking of the B cell CD40 antigen, a member of the tumor necrosis factor (TNF) receptor family, results in major cellular activation further modulated by cytokines. In particular, IL-4 and IL-13 permit establishment of long-term factor-dependent B cell lines, as well as isotype switch towards the production of IgE and IgG4. Addition of IL-10 to CD40-activated B cells results in limited proliferation and remarkable differentiation into plasma cells. IL-10 also participates in isotype switch towards IgG1, IgG3 and IgA. The ligand for CD40, a member of the TNF family, is transiently expressed on activated T cells, and interrupted CD40/CD40-L interactions result in profoundly altered humoral immune responses.Keywords
This publication has 95 references indexed in Scilit:
- Recombinant CD40 ligand stimulation of murine B cell growth and differentiation: cooperative effects of cytokinesEuropean Journal of Immunology, 1993
- lnterleukin-13 is a new human lymphokine regulating inflammatory and immune responsesNature, 1993
- The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndromeCell, 1993
- Human CD40‐ligand: molecular cloning, cellular distribution and regulation of expression by factors controlling IgE productionFEBS Letters, 1993
- Germinal centres in T-cell-dependent antibody responsesImmunology Today, 1992
- Identification of a source of biologically active CD40 ligandEuropean Journal of Immunology, 1992
- Germinal center cells express bcl‐2 protein after activation by signals which prevent their entry into apoptosisEuropean Journal of Immunology, 1991
- Cognate interactions between helper T cells and B cellsImmunology Today, 1990
- The induction of human B-cell activation, proliferation and differentiation by anti-CD3-stimulated T cells — A model of T cell/B cell collaborationResearch in Immunology, 1990
- Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cellsNature, 1984